Order Article Reprints

Delmonico L, Bines J, Nascimento CMd, Fernandes PV, Barbosa IdS, Ribeiro GB, de Paula BHR, Silvestre RT, Ornellas MHF, Alves G, et al. Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer. Current Oncology. 2023; 30(4):4094-4109. https://doi.org/10.3390/curroncol30040311

Delmonico, Lucas, José Bines, Cristina Moreira do Nascimento, Priscila Valverde Fernandes, Isabel de Souza Barbosa, Gabriel Brito Ribeiro, Bruno Henrique Rala de Paula, Rafaele Tavares Silvestre, Maria Helena Faria Ornellas, Gilda Alves, and et al. 2023. "Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer" Current Oncology 30, no. 4: 4094-4109. https://doi.org/10.3390/curroncol30040311

Delmonico, L., Bines, J., Nascimento, C. M. d., Fernandes, P. V., Barbosa, I. d. S., Ribeiro, G. B., de Paula, B. H. R., Silvestre, R. T., Ornellas, M. H. F., Alves, G., & Lage, C. (2023). Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer. Current Oncology, 30(4), 4094-4109. https://doi.org/10.3390/curroncol30040311